Latest Earnings Analysis

• CELH Q2 2025: Alani New Adds $301M, Expanding Portfolio Scale and Margin Leverage
  August 07, 2025 · CELH
• Lexin (LX) Q2 2025: E-commerce Gross Profit Jumps 71% as Risk Controls Tighten
  August 07, 2025 · LX
• Immunocore (IMCR) Q2 2025: ChemTrack Europe Revenue Jumps 115% as Global Expansion Drives Pipeline Investment
  August 07, 2025 · IMCR
• Alamo Group (ALG) Q2 2025: Industrial Equipment Orders Jump 21%, Driving Margin Expansion
  August 07, 2025 · ALG
• NSYS Q2 2025: Backlog Jumps $10M as Fiber Optic Shift Drives Margin Rebound
  August 07, 2025 · NSYS
• CrossAmerica Partners (CAPL) Q2 2025: $64M Asset Sales Reshape Portfolio, Debt Cut by $51M
  August 07, 2025 · CAPL
• Hanesbrands (HBI) Q2 2025: Operating Margin Expands 255bps as Cost Actions Drive Structural Profitability
  August 07, 2025 · HBI
• Brilliant Earth (BRLT) Q2 2025: Fine Jewelry Bookings Surge 38%, Driving Brand Momentum and Dividend Payout
  August 07, 2025 · BRLT
• Fathom (PHAT) Q2 2025: 39% Revenue Jump Anchors GI-First Pivot and Cost Reset
  August 07, 2025 · PHAT
• New Health (NEUE) Q2 2025: Consumer Base Surges 45%, Anchoring Value-Based Care Scale
  August 07, 2025 · NEUE
• Watts Water (WTS) Q2 2025: Americas Margin Surges 290bps, Tariff Strategy Drives Outperformance
  August 07, 2025 · WTS
• Viatris (VTRS) Q2 2025: $350M Buybacks Signal Commitment to Shareholder Returns Amid Pipeline Momentum
  August 07, 2025 · VTRS
• Walker & Dunlop (WD) Q2 2025: Transaction Volume Soars 65% as Market Cycle Turns
  August 07, 2025 · WD
• XRAY Q2 2025: Tariff Headwind Rises to $80M, Margin Expansion Holds Amid U.S. Weakness
  August 07, 2025 · XRAY
• Vital Energy (VTLE) Q2 2025: $25M Annualized G&A Cut Resets Cost Base for Debt Paydown
  August 07, 2025 · VTLE
• Yeti (YETI) Q2 2025: Bags and Packs Surge, Offsetting 4% Drinkware Decline Amid Tariff Relief
  August 07, 2025 · YETI
• Warner Bros Discovery (WBD) Q2 2025: Studio EBITDA on Track for $2.4B as Franchise Strategy Drives Global Streaming Scale
  August 07, 2025 · WBD
• Warby Parker (WRBY) Q2 2025: Retail Revenue Jumps 19% as Store Expansion and AI Drive Growth
  August 07, 2025 · WRBY
• ZLAB Q2 2025: Operating Loss Narrows 28% as Pipeline Advancements Drive Profitability Path
  August 07, 2025 · ZLAB
• VTEX (VTEX) Q1 2025: Gross Margin Jumps 371bps as Retail Media and B2B Suite Scale
  August 07, 2025 · VTEX
• UGI (UGI) Q3 2025: $150M LPG Divestitures Drive Portfolio Focus and Deleveraging Momentum
  August 07, 2025 · UGI
• United Homes Group (UHG) Q2 2025: Gross Margin Rises 100bps as Product Refresh Offsets Demand Dip
  August 07, 2025 · UHG
• SolarEdge (SEDG) Q2 2025: Gross Margin Improves by 530bps as Turnaround Gains Traction
  August 07, 2025 · SEDG
• RXO (RXO) Q2 2025: LTL Volume Jumps 45% as Platform Synergies Drive Margin Outperformance
  August 07, 2025 · RXO
• Super Group (SGHC) Q2 2025: Ex-U.S. EBITDA Guidance Raised $25M as Margin Expansion Accelerates
  August 07, 2025 · SGHC
• Privia Health (PRVA) Q2 2025: EBITDA Margin Expands 310bps on Platform-Driven Growth
  August 07, 2025 · PRVA
• PODD Q2 2025: International Omnipod 5 Adoption Hits 50%, Driving Durable Margin Expansion
  August 07, 2025 · PODD
• Pagaya (PGY) Q2 2025: Fee Revenue Climbs 31% as Product-Led Model Drives Margin Expansion
  August 07, 2025 · PGY
• PX Q2 2025: Fee-Paying AUM Jumps 21% as Secondary and Credit Momentum Accelerate Platform Scale
  August 07, 2025 · PX
• Playtika (PLTK) Q2 2025: Disney Solitaire Hits $100M Run Rate, D2C Target Raised to 40%
  August 07, 2025 · PLTK
• Nuvation Bio (NUVB) Q2 2025: 70 Iptrosi Patients in 7 Weeks Signals Accelerating Launch Trajectory
  August 07, 2025 · NUVB
• Murphy Oil (MUR) Q2 2025: $700M Cost Cuts, 500M+ BOE Exploration Catalysts Shape Portfolio Inflection
  August 07, 2025 · MUR
• MATV Q2 2025: $40M Sequential Sales Jump Signals Turnaround Traction
  August 07, 2025 · MATV
• MKS Instruments (MKSI) Q2 2025: Chemistry Revenue Climbs 10% as AI Demand Reshapes Growth Mix
  August 07, 2025 · MKSI
• Insmed (INSM) Q2 2025: $823M Capital Raise Powers Brenzocatib Launch and Pipeline Acceleration
  August 07, 2025 · INSM
• Calterra (KLTR) Q2 2025: ENT Revenue Climbs 7% as AI Monetization and Cost Actions Reshape Outlook
  August 07, 2025 · KLTR
• LifeStance Health (LFST) Q2 2025: Free Cash Flow Hits $57M as Productivity Initiatives Accelerate
  August 07, 2025 · LFST
• Kenview (KVUE) Q2 2025: Organic Sales Fall 4.2% as Complexity and Execution Drag on Turnaround
  August 07, 2025 · KVUE
• Acushnet (GOLF) Q2 2025: Tariffs Add $30M Headwind, Equipment and Gear Offset Asia Drag
  August 07, 2025 · GOLF
• Humanetics (HAE) Q1 2026: Plasma Organic Growth Hits 29% as Execution Drives Margin Expansion
  August 07, 2025 · HAE
• Genco Shipping (GNK) Q2 2025: Capesize Exposure Tops 50% of Net Revenue as Operating Leverage Builds
  August 07, 2025 · GNK
• DraftKings (DKNG) Q2 2025: Parlay Mix Up 430 bps, Accelerating Hold and Margin Expansion
  August 07, 2025 · DKNG
• DHT (DHT) Q2 2025: $308M Credit Facility Secured as Fleet Renewal Accelerates
  August 07, 2025 · DHT
• Catalyst (CPRX) Q2 2025: Agamree Revenue Jumps 213% as Oncology Push Accelerates
  August 07, 2025 · CPRX
• CommScope (COMM) Q2 2025: $10.5B CCS Sale Unlocks Equity Value as ANS and Ruckus Surge 58%
  August 07, 2025 · COMM
• Americold (COLD) Q2 2025: Fixed Commit Contracts Hit 60% as Guidance Tightens on Demand Weakness
  August 07, 2025 · COLD
• Civitas (CIVI) Q2 2025: $750M Buyback Authorization Signals Shift Toward Aggressive Capital Return
  August 07, 2025 · CIVI
• CRH (CRH) Q2 2025: Margin Expands 70bps as Connected Portfolio Drives 9% EBITDA Growth
  August 07, 2025 · CRH
• Collegium (COLL) Q2 2025: Jornay PM Drives 23% Rx Growth, Powering Guidance Raise and Portfolio Durability
  August 07, 2025 · COLL
• Sentara-Bold (CGAU) Q2 2025: Goldfield Project Adds $245M NPV, Secures Growth Amid Rising Costs
  August 07, 2025 · CGAU